Protagenic Therapeutics I... (PTIX)
0.28
-0.02 (-8.20%)
At close: Mar 03, 2025, 3:59 PM
0.50
81.32%
After-hours: Mar 03, 2025, 07:59 PM EST
Protagenic Therapeutics Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 |
Net Income | -5M | -3.56M | -4.52M | -2.55M | -1.75M | -2.56M | -2.26M | -2.28M | -476K | -1.08M | -1.03M | -19.73M | -29.44M | -115.77M | -4.15M | 677K | -94.47K | -1.33M | -7.9M | -728K | 144K | 1.14M | -674K | 648K | -858K | -500K | -800K |
Depreciation & Amortization | 28.22K | 30.00 | 427.14K | 286.00 | 339.00 | 347.00 | 148.00 | 534.00 | 1K | 0.38 | 1.20 | 1.64M | 3.7M | 5.87M | 1.35M | 25K | n/a | n/a | 2.49M | 2.09M | 2.03M | 1.89M | 1.91M | 1.55M | 1.12M | 1.05M | 1.1M |
Stock-Based Compensation | 666.83K | 864.68K | 1.52M | 1.65M | 797.76K | 1.13M | 888.28K | 546.13K | 478.63 | 275K | 603.78 | 1.11M | 857K | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -87.09K | 631.73K | -480.51K | -361.43K | 602.66K | 11.14K | -34.13K | -54.19K | 74K | 93K | 995K | 1.03M | -6.96M | -2.08M | -1.96M | 373K | n/a | n/a | -6.88M | 735K | -57K | 52K | -537K | -1.54M | -1.16M | 1.31M | -920K |
Other Non-Cash Items | 716.09K | 156.85K | 345.95K | 154.9K | 110.91K | 246.19K | 99.78K | 150K | -7K | -46K | 106.74 | 4.81M | 19.44M | 116.07M | 419K | 375K | n/a | 485K | 10.85M | n/a | n/a | n/a | n/a | 174K | 150K | -470K | 20K |
Deferred Income Tax | n/a | n/a | -427.14K | -248.55K | -348.29K | n/a | -91.8K | 440.78K | n/a | n/a | n/a | -1.54M | 3.65M | -2.35M | -1.15M | 183K | n/a | n/a | n/a | n/a | -241K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -114.41K | 540.13K | -140.39K | -361.43K | 702.2K | 109.73K | -16.87K | -1.94K | 104K | 60K | 703K | 2.45M | -1.22M | -752K | -1.96M | -329K | 50.47K | n/a | -3.57M | 980K | -426K | 482K | -907K | -2.8M | -2.62M | -310K | -920K |
Operating Cash Flow | -3.7M | -1.99M | -2.8M | -1.35M | -487.99K | -1.07M | -1.38M | -1.14M | -378K | -790K | -324K | -11.25M | -3.02M | 4.36M | -5.21M | 931K | -44K | -842K | 1.87M | 2.35M | 1.5M | 3.51M | 331K | -434K | -2.2M | -230K | -600K |
Capital Expenditures | -149.78K | -1.8K | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | n/a | -41K | -682K | -2.03M | -266K | -77K | n/a | n/a | -1.48M | -1.78M | -3.79M | -3.23M | -81K | -65K | -2.86M | -1.42M | -1.33M |
Acquisitions | n/a | 46.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.74M | 4.18M | -970K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -2.76M | -34.12K | -10.4M | n/a | n/a | -2.74M | -3.43M | n/a | n/a | n/a | n/a | n/a | -914K | -9.1M | -3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 7.69M | 1.63M | 485.95K | n/a | 250K | 3.79M | 2.15M | n/a | n/a | n/a | n/a | 720K | 6.18M | 24.71M | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -46.05K | -9.91K | n/a | 250.00 | 1.05K | -1.29K | n/a | n/a | 15K | 15K | n/a | -480K | n/a | -1.05M | -123K | n/a | 6.43M | n/a | n/a | 1.84M | 1.57M | -1.73M | -3.67M | 1.4M | n/a | n/a |
Investing Cash Flow | 4.78M | 1.6M | -9.91M | n/a | 250K | 1.05M | -1.29M | n/a | -1K | -1K | 15K | 679K | 2.37M | 17.77M | -5.18M | -200K | n/a | 6.43M | -1.48M | -1.78M | -1.95M | -1.66M | -1.81M | -3.73M | -1.46M | -1.42M | -1.33M |
Debt Repayment | n/a | n/a | n/a | 1.33M | 670K | n/a | n/a | 19K | 340K | 175K | n/a | n/a | -1.75M | -111K | -587K | -324K | 14K | n/a | n/a | -604K | 482K | 764K | n/a | 3.88M | -3.24M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100 | -9K | -939K | -4.05M | n/a | n/a | n/a | n/a | n/a | n/a | -20K | -967K | n/a | n/a | n/a | n/a | 1.5M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 869.63K | -104.09K | n/a | n/a | n/a | 8.52M | n/a | n/a | 31K | n/a | -150K | 1.36M | -469K | -213K | 30K | n/a | -300K | -9K | n/a | -1.77M | 1.58M | n/a | n/a | 1.24M | 2.1M |
Financial Cash Flow | n/a | n/a | 12.58M | 1.22M | 670K | n/a | n/a | 4.28M | 340K | 175K | 31K | -9K | -2.84M | -2.8M | 17.46M | -537K | 44K | n/a | -300K | -568K | 462K | -1.98M | 1.58M | 3.88M | 3.85M | 1.24M | 2.1M |
Net Cash Flow | 1.07M | -325.98K | -129.92K | -127.53K | 436.14K | -37.2K | -2.7M | 3.1M | -39K | -616K | -278K | -10.59M | -3.5M | 19.3M | 7.07M | 194K | n/a | 4.42M | 90K | -5K | 16K | -133K | 99K | -289K | 189K | -400K | 170K |
Free Cash Flow | -3.85M | -2M | -2.8M | -1.35M | -487.99K | -1.07M | -1.38M | -1.14M | -379K | -791K | -324K | -11.29M | -3.7M | 2.33M | -5.48M | 854K | -44K | -842K | 390K | 563K | -2.29M | 278K | 250K | -499K | -5.06M | -1.65M | -1.93M |